SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-06-053261
Filing Date
2006-08-09
Accepted
2006-08-09 17:21:54
Documents
7
Period of Report
2006-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT PURSUANT TO SECTIONS 13 OR 15(D) a06-15580_110q.htm 10-Q 1114139
2 EX-10 a06-15580_1ex10d1.htm EX-10.1 1239538
3 EX-10 a06-15580_1ex10d2.htm EX-10.2 13491
4 EX-31 a06-15580_1ex31d1.htm EX-31.1 9147
5 EX-31 a06-15580_1ex31d2.htm EX-31.2 9273
6 EX-32 a06-15580_1ex32d1.htm EX-32.1 8731
7 GRAPHIC g155802kqi001.gif GRAPHIC 1997
  Complete submission text file 0001104659-06-053261.txt   2398518
Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19319 | Film No.: 061018737
SIC: 2834 Pharmaceutical Preparations